Sterling Capital Management
MBX icon

Sterling Capital Management’s MBX Biosciences MBX Stock Holding History

Sterling Capital Management’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$60.6K Buy
1,033
+924
+848% +$57.8K ﹤0.01% 1676
2026
Q2 		$6.02K Sell
109
-840
-89% -$29.3K ﹤0.01% 2513
2026
Q1 		$28.3K Sell
949
-692
-42% -$23.5K ﹤0.01% 1862
2025
Q4 		$51.8K Buy
1,641
+583
+55% +$14.1K ﹤0.01% 1790
2025
Q3 		$18.5K Buy
1,058
+598
+130% +$8K ﹤0.01% 2181
2025
Q2 		$5.25K Buy
460
+369
+405% +$3.76K ﹤0.01% 2483
2025
Q1 		$672 Sell
91
-70
-43% -$740 ﹤0.01% 2917
2024
Q4 		$2.97K Buy
+161
New +$3.43K ﹤0.01% 2649

Other funds holding MBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Sterling Capital Management's MBX Position: Q3 2026 in Review

Sterling Capital Management increased its MBX Biosciences (MBX) stake by 848% in Q3 2026, buying an estimated $57.8K and bringing the position to 1,033 shares worth $60.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1676.

Sterling Capital Management first reported a position in MBX in Q4 2024 and has held it in 8 quarters since. 90 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

  • Sterling Capital Management held 1,033 shares of MBX Biosciences worth $60.6K as of Q3 2026.
  • Sterling Capital Management bought 924 MBX Biosciences shares in Q3 2026, an estimated $57.8K.
  • MBX Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1676 holding.
  • Sterling Capital Management first reported a position in MBX Biosciences in Q4 2024 and has held it in 8 quarters since.
  • 90 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.